Clinical reviews

93 available of 93 resources in this folder (including subfolders)

Clinical reviewsNOVEL ANTIBIOTICS FOR THE TREATMENT OF INFECTIONS CAUSED BY MDR BACTERIADepartments of Internal Medicine and Critical Care Medicine, Min-Sheng General Hospital, Taoyuan, Taiwan·Infectious Diseases· 2023· 15 pages

Clinical reviewsEFFICACY AND SAFETY OF PIPERACILLIN-TAZOBACTAM COMPARED WITH MEROPENEM IN TREATING COMPLICATED URINARY TRACT INFECTIONS INCLUDING ACUTE PYELONEPHRITIS DUE TO EXTENDED-SPECTRUM β-LACTAMASE-PRODUCING ENTEROBACTERIACEAEZhejiang University, China; Charles Sturt University, Australia; Kharkiv Medical Academy of Postgraduate Education, Ukraine·Infectious Diseases· 2023· 11 pages

Clinical reviewsINVASIVE CANDIDIASIS: CURRENT CLINICAL CHALLENGES AND UNMET NEEDS IN ADULT POPULATIONSDepartment of Infectious Diseases, Hospital Clinic of Barcelona, IDIBAPS, CIBERINF, University of Barcelona, Barcelona, Spain; CHU UCL Godinne Namur, UCL Louvain Medical School, Namur, Belgium; Symmetron Ltd, London, UK; Radboudumc-CWZ Center of·Infectious Diseases· 17 pages

Clinical reviewsFEVER AND FEVER OF UNKNOWN ORIGIN: REVIEW, RECENT ADVANCES, AND LINGERING DOGMAJohns Hopkins University School of Medicine·Infectious Diseases· 12 pages

Clinical reviewsEVALUATION AND MANAGEMENT OF DIABETES-RELATED FOOT INFECTIONSUniversity of Nebraska Medical Center, University of Southern California, University of Wisconsin, Emory University, Grady Memorial Hospital·Infectious Diseases· 13 pages

Clinical reviewsUPDATE ON MALARIAISGlobal, Hospital Clínic, Universitat de Barcelona; Centro de Investigação em Saúde de Manhiça; Ifakara Health Institute; Universidad de Navarra; Hospital Sant Joan de Deu·Infectious Diseases· 2020· 8 pages

Clinical reviewsEFFICACY AND SAFETY OF SULBACTAM–DURLobactam VERSUS COLISTIN FOR THE TREATMENT OF PATIENTS WITH SERIOUS INFECTIONS CAUSED BY ACINETOBACTER BAUMANNII–CALCOACETICUS COMPLEX: A MULTICENTRE, RANDOMISED, ACTIVE-CONTROLLED, PHASE 3, NON-INFERIORITY CLINICALKeith S Kaye, Andrew F Shorr, Richard G Wunderink, Bin Du, Gabrielle E Poirier, Khurram Rana, Alita Miller, Drew Lewis, John O'Donnell, Lan Chen, Harald Reinhart, Subasree Srinivasan, Robin Isaacs, David Altarac·Infectious Diseases· 13 pages

Clinical reviewsTHE 2023 DUKE - ISCVID CRITERIA FOR INFECTIVE ENDOCARDITIS: UPDATING THE MODIFIED DUKE CRITERIADuke University Medical Center; Duke Clinical Research Institute·Infectious Diseases· 2023· 22 pages

Clinical reviewsEVALUATING ANTIMICROBIAL DURATION FOR GRAM-NEGATIVE BACTEREMIA IN PATIENTS WITH NEUTROPENIA DUE TO HEMATOLOGIC MALIGNANCY OR HEMATOPOIETIC STEM CELL TRANSPLANTATIONMayo Clinic, Rochester, Minnesota, USA·Infectious Diseases· 2023· 9 pages

Clinical reviewsTHE USE OF URINALYSIS AND URINE CULTURE IN DIAGNOSIS: THE ROLE OF UNCERTAINTY TOLERANCEUniversity Health Network, Toronto, Ontario; Department of Medicine, University of Toronto, Ontario·Infectious Diseases· 2023· 6 pages

Clinical reviewsNONTYPHOIDAL SALMONELLA INVASIVE DISEASE: CHALLENGES AND SOLUTIONSCentre for International Health, University of Otago; Malawi Liverpool Wellcome Trust Programme; Institute of Infection, Veterinary, and Ecological Sciences, University of Liverpool; Department of Pathology, Kamuzu University of Health Sciences;·Infectious Diseases· 2023· 6 pages

Clinical reviewsFungal Infections, Treatment and Antifungal Resistance: The Sub-Saharan African ContextEmily Boakye-Yiadom, Alex Odoom, Abdul-Halim Osman, Onyansaniba K. Ntim, Fleischer C. N. Kotey, Bright K. Ocansey, Eric S. Donkor·Infectious Diseases· 2024· 25 pages

Clinical reviewsANTIBIOTIC MYTHS FOR THE INFECTIOUS DISEASES CLINICIANUniversity of Pittsburgh School of Medicine; Duke University Medical Center; Temple University·Infectious Diseases· 2023· 13 pages

Clinical reviewsHYBRID IMMUNITY MORE PROTECTIVE THAN PRIOR SARS-CoV-2 INFECTION ALONEInfectious Diseases· 2023· 2 pages

Clinical reviewsBEDAQUILINE, PRETOMANID, LINEZOLID, AND MOXIFLOXACIN: MECHANISMS OF ACTION, DRUG INTERACTIONS, ADVERSE EFFECTS AND USE IN SPECIAL SITUATIONSMedical School, University of Araraquara (Uniara), Araraquara, Brazil·Infectious Diseases· 34 pages

Clinical reviewsFUNGAL DIMORPHISM AND VIRULENCE: MOLECULAR MECHANISMS FOR TEMPERATURE ADAPTATION, IMMUNE EVASION, AND IN VIVO SURVIVALUniversity of Wisconsin School of Medicine & Public Health·Infectious Diseases· 2017· 8 pages

Clinical reviewsCOMMUNITY-BASED STRATEGIES TO STRENGTHEN MEN'S ENGAGEMENT IN THE HIV CARE CASCADE IN SUB-SAHARAN AFRICAUniversity of Washington, Seattle, Washington, United States of America·Infectious Diseases· 2017· 13 pages

Clinical reviewsTHINGS WE DO FOR NO REASON™: ROUTINE CD4 TESTING IN HOSPITALIZED PATIENTS WITH HIVJohns Hopkins University School of Medicine·Infectious Diseases· 2026· 3 pages

Clinical reviewsPROGRESS AND CHALLENGES IN BACTERIAL MENINGITISRodrigo Hasbun, MD, MPH·Infectious Diseases· 2022· 8 pages

Clinical reviewsWHEN ORAL THERAPY CAN REPLACE INTRAVENOUS ANTIBIOTICS—CHANGING PRACTICE AS NEW DATA EMERGELos Angeles County and University of Southern California (LAC+USC) Medical Center·Infectious Diseases· 2023· 2 pages

Clinical reviewsCOMPLICATIONS OF COVID 19Infectious Diseases· 14 pages

Clinical reviewsPMTCT updateWorld Health Organization (WHO)·Infectious Diseases· 2012· 7 pages

Clinical reviewsECHO SUMMARY, 26/APR/2024Kayunga RRH, Makerere University·Infectious Diseases· 2024· 8 pages

Clinical reviewsANNEX 1: THE THERAPEUTIC RESPONSE TO ANTIMALARIAL DRUGSROYAL SOCIETY OF MEDICINE AND HYGIENE·Infectious Diseases· 2000· 9 pages